VivoSim Labs, Inc. Debt Securities, Available-for-sale, Unrealized Gain (Loss)
VivoSim Labs, Inc. (VIVS) reported Debt Securities, Available-for-sale, Unrealized Gain (Loss) of -$1.00 thousand for the 3-month period ending 2024-12-31, per its 10-Q filed 2026-02-11.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedGainLoss · last filed 2026-02-11
- VivoSim Labs, Inc. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2024-12-31 was -$1.00K.
- VivoSim Labs, Inc. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2024-09-30 was $1.00K.
- VivoSim Labs, Inc. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2023-09-30 was -$1.00K.
- VivoSim Labs, Inc. debt securities, available-for-sale, unrealized gain (loss) for the quarter ending 2022-12-31 was $3.00K.
- VivoSim Labs, Inc. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2024 was -$2.00K, a 200.00% decline from fiscal 2023.
- VivoSim Labs, Inc. debt securities, available-for-sale, unrealized gain (loss) for fiscal 2023 was $2.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Unrealized Gain (Loss) 12 month |
|---|---|---|---|
| 2024-12-31 | -$1.00K 10-Q · filed 2026-02-11 | $0.00 derived: sum of 2 quarters · filed 2026-02-11 | |
| 2024-09-30 | $1.00K 10-Q · filed 2026-02-11 | ||
| 2024-03-31 | -$2.00K 10-K · filed 2025-06-05 | ||
| 2023-09-30 | -$1.00K 10-Q · filed 2025-02-19 | ||
| 2023-03-31 | $2.00K 10-K · filed 2024-05-31 | ||
| 2022-12-31 | $3.00K 10-Q · filed 2024-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |